Notification of cessation of +securities
Announcement Summary
For personal use only
Entity name
ZELIRA THERAPEUTICS LIMITED
Announcement Type
New announcement
Date of this announcement
Monday February 21, 2022
Details of +securities that have ceased
Number of | ||||
ASX +security | +securities that | The +securities have | Date of | |
code | Security description | have ceased | ceased due to | cessation |
ZLDAA | OPTION EXPIRING | 25,000,000 Expiry of option or other | 19/02/2022 | |
VARIOUS DATES EX | convertible security without | |||
VARIOUS PRICES | exercise or conversion |
Refer to next page for full details of the announcement
Notification of cessation of +securities | 1 / 6 |
Notification of cessation of +securities
Part 1 - Announcement Details
For personal use only
1.1 Name of +Entity
ZELIRA THERAPEUTICS LIMITED
We (the entity named above) provide the following information about our issued capital.
1.2 | Registered Number Type | Registration Number |
ABN | 27103782378 | |
1.3 | ASX issuer code | |
ZLD |
- The announcement is New announcement
- Date of this announcement
21/2/2022
Notification of cessation of +securities | 2 / 6 |
Notification of cessation of +securities
Part 2 - Details of +equity securities or +debt securities that have ceased
For personal use only
ASX +Security Code and Description
ZLDAA : OPTION EXPIRING VARIOUS DATES EX VARIOUS PRICES
Unquoted +equity securities that have ceased
Number of securities that have ceased
5,000,000
Reason for cessation
Expiry of option or other convertible security without exercise or conversion
Date of cessation | Is the entity paying any consideration for the cessation? |
19/2/2022 | No |
Any other information the entity wishes to notify to ASX about the cessation?
Exercisable at $0.10 on or before 19 February 2022
ASX +Security Code and Description
ZLDAA : OPTION EXPIRING VARIOUS DATES EX VARIOUS PRICES
Unquoted +equity securities that have ceased
Number of securities that have ceased
5,000,000
Reason for cessation
Expiry of option or other convertible security without exercise or conversion
Date of cessation | Is the entity paying any consideration for the cessation? |
19/2/2022 | No |
Any other information the entity wishes to notify to ASX about the cessation?
Exercisable at $0.15 on or before 19 February 2022
ASX +Security Code and Description
ZLDAA : OPTION EXPIRING VARIOUS DATES EX VARIOUS PRICES
Unquoted +equity securities that have ceased
Number of securities that have ceased
5,000,000
Notification of cessation of +securities | 3 / 6 |
Notification of cessation of +securities
Reason for cessation
Expiry of option or other convertible security without exercise or conversion
For personal use only
Date of cessation | Is the entity paying any consideration for the cessation? |
19/2/2022 | No |
Any other information the entity wishes to notify to ASX about the cessation?
Exercisable at $0.30 on or before 19 February 2022
ASX +Security Code and Description
ZLDAA : OPTION EXPIRING VARIOUS DATES EX VARIOUS PRICES
Unquoted +equity securities that have ceased
Number of securities that have ceased
5,000,000
Reason for cessation
Expiry of option or other convertible security without exercise or conversion
Date of cessation | Is the entity paying any consideration for the cessation? |
19/2/2022 | No |
Any other information the entity wishes to notify to ASX about the cessation?
Exercisable at $0.20 on or before 19 February 2022
ASX +Security Code and Description
ZLDAA : OPTION EXPIRING VARIOUS DATES EX VARIOUS PRICES
Unquoted +equity securities that have ceased
Number of securities that have ceased
5,000,000
Reason for cessation
Expiry of option or other convertible security without exercise or conversion
Date of cessation | Is the entity paying any consideration for the cessation? |
19/2/2022 | No |
Any other information the entity wishes to notify to ASX about the cessation?
Exercisable at $0.28 on or before 19 February 2022
Notification of cessation of +securities | 4 / 6 |
Notification of cessation of +securities
For personal use only
Notification of cessation of +securities | 5 / 6 |
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Zelda Therapeutics Ltd. published this content on 21 February 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 21 February 2022 03:10:08 UTC.